Search by Drug Name or NDC

    NDC 53809-0203-04 DOMETUSS-DMX 30; 200; 10 mg/5mL; mg/5mL; mg/5mL Details

    DOMETUSS-DMX 30; 200; 10 mg/5mL; mg/5mL; mg/5mL

    DOMETUSS-DMX is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Domel Laboratories. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 53809-0203
    Product ID 53809-203_c16cfa01-24f0-46ba-982b-d308f48ae669
    Associated GPIs 43997303100935
    GCN Sequence Number 029083
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 200-30-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 53086
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Generic
    Proprietary Name DOMETUSS-DMX
    Proprietary Name Suffix n/a
    Non-Proprietary Name GUAIFENESIN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 30; 200; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Domel Laboratories
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 53809-0203-04 (53809020304)

    NDC Package Code 53809-203-04
    Billing NDC 53809020304
    Package 118 mL in 1 BOTTLE (53809-203-04)
    Marketing Start Date 2016-01-21
    NDC Exclude Flag N
    Pricing Information N/A